Abstract:Rationale: The coronavirus disease (COVID-19) pandemic is now a global health concern. Objectives: We compared the clinical characteristics, laboratory examinations, computed tomography images, and treatments of patients with COVID-19 from three different cities in China. Methods: A total of 476 patients were recruited from January 1, 2020, to February 15, 2020, at three hospitals in Wuhan, Shanghai, and Anhui. The patients were divided into four groups according to age and into three groups (moderate, severe, and critical) according to the fifth edition of the Guidelines on the Diagnosis and Treatment of COVID-19 issued by the National Health Commission of China. Measurements and Main Results: The incidence of comorbidities was higher in the severe (46.3%) and critical (67.1%) groups than in the moderate group (37.8%). More patients were taking angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers in the moderate group than in the severe and critical groups. More patients had multiple lung lobe involvement and pleural effusion in the critical group than in the moderate group. More patients received antiviral agents within the first 4 days in the moderate group than in the severe group, and more patients received antibiotics and corticosteroids in the critical and severe groups. Patients >75 years old had a significantly lower survival rate than younger patients. Conclusions: Multiple organ dysfunction and impaired immune function were the typical characteristics of patients with severe or critical illness. There was a significant difference in the use of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers among patients with different severities of disease. Involvement of multiple lung lobes and pleural effusion were associated with the severity of COVID-19. Advanced age (≥75 yr) was a risk factor for mortality.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to understand the differences in clinical features, laboratory test results, CT imaging findings and treatment among COVID - 19 patients with different severities. Specifically, the study aims to: 1. **Compare the clinical features of patients with different severities**: including age, gender, underlying diseases, the time from the appearance of symptoms to diagnosis, symptoms at admission, etc. 2. **Analyze laboratory test results**: such as hematological indicators, biochemical indicators, immunological indicators, etc., in order to evaluate the differences among patients with different severities. 3. **Describe CT imaging features**: including the extent of lung involvement, the presence or absence of pleural effusion, etc., and the relationship between these features and the severity of the disease. 4. **Explore treatment regimens and their effects**: including antiviral treatment, antibiotic use, corticosteroid use, etc., and the impact of these treatments on the prognosis of patients. 5. **Evaluate the clinical outcomes of patients in different age groups**: especially elderly patients over 75 years old, whether their disease severity and risk of death are higher. Through the above - mentioned analysis, the study hopes to provide a basis for clinicians to identify high - risk patients and guide more effective treatment strategies.

COVID-19 with Different Severities: A Multicenter Study of Clinical Features